Spotlight -

Drug Development|

Quality Systems

Thomas Baxter

Articles by Thomas Baxter

Addressing Segregation of a Low-Dosage Direct Blend

ByNipun Davar,Pauly Kavalakatt,Sangita Ghosh,Thomas Baxter,Herbert Schock

February 2nd 2011

The authors modified equipment and the manufacturing process to re-establish content uniformity among tablets.

Latest Updated Articles

Addressing Segregation of a Low-Dosage Direct Blend
February 2nd 2011

Trending on Pharmaceutical Technology

Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral

What the Olanzapine Depot Approval Means for CMC Teams

Complying with International Pharmacopoeias

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2

Q&A: Patient-Centric Drug Development Should Start at Product Definition